GlassScriptPhysician profile
John J Condemi
NPI 1881662039
$1,107.68
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $125 · 2021: $76.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $263.69 | 2019 | |
| Glaxosmithkline, LLC. | $202.78 | 2019-2020 | |
| Phadia US INC. | $75.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $48.64 | 2019-2021 | |
| Janssen Biotech, INC. | $46.79 | 2019-2020 | |
| Abbvie INC. | $45.51 | 2019 | |
| Amgen INC. | $41.16 | 2019-2020 | |
| Biocryst US Sales Co., LLC | $39.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $39.41 | 2019-2020 | |
| Grifols USA, LLC | $31.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.92 | 2019 | |
| Optinose US, INC. | $29.46 | 2019-2020 | |
| Lilly USA, LLC | $29.08 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.44 | 2019-2020 | |
| Pfizer INC. | $23.87 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $22.70 | 2019 | |
| Alk-Abello, INC | $22.14 | 2019 | |
| Genzyme Corporation | $20.50 | 2019 | |
| Sanofi Pasteur INC. | $20.36 | 2019 | |
| Pharming Healthcare, INC. | $18.77 | 2019 | |
| Fidia Pharma USA INC. | $16.52 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.21 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Condemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.